Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected miceJu Hwan Jeong, Min‐Suk Song, Santosh Chokkakula et al.|Antiviral Research|2022Cited by 82
Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination TherapySania Batool, Min‐Suk Song, Santosh Chokkakula|Microorganisms|2023Cited by 77
SARS-CoV-2 drug resistance and therapeutic approachesSania Batool, Min‐Suk Song, Santosh Chokkakula et al.|Heliyon|2025Cited by 44
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected miceJu Hwan Jeong, Min‐Suk Song, Santosh Chokkakula et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 10
Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronavirusesJu Hwan Jeong, Min‐Suk Song, Jang‐Hoon Choi et al.|Antiviral Research|2023Cited by 7